Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, Pennsylvania
- Most recent report
- 8-K, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1534120
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 44
News 8 of 186
Prospectuses and Registrations 8 of 80
- S-3ASR Automatic shelf registration Nov 5, 2026
- 424B5 Prospectus supplement for an offering Nov 5, 2026
- 424B3 Prospectus supplement for an offering Jul 28, 2026
- S-3 Shelf registration statement Jul 17, 2026
- 424B5 Prospectus supplement for an offering May 7, 2026
- 424B5 Prospectus supplement for an offering May 5, 2026
- S-8 Registration statement for an employee plan Mar 23, 2026
- S-3 Shelf registration statement Jan 8, 2026
Proxies 8 of 29
- DEFA14A Extra proxy material Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- DEFA14A Extra proxy material May 1, 2025
- DEF 14A Proxy statement for a shareholder vote May 1, 2025
- DEFA14A Extra proxy material Jun 27, 2024
- DEF 14A Proxy statement for a shareholder vote Jun 27, 2024
- PRE 14A Preliminary proxy statement Jun 7, 2024
- DEFA14A Extra proxy material Mar 28, 2024
Ownership 8 of 605
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 29, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Sep 18, 2026
- 4 Insider reported a trade Sep 11, 2026
Other 8 of 58
- EFFECT Notice that a registration became effective Jul 28, 2026
- ARS Annual report sent to shareholders Apr 10, 2026
- EFFECT Notice that a registration became effective Jan 20, 2026
- CORRESP Reply to SEC staff Jan 15, 2026
- UPLOAD Comment letter from SEC staff Jan 14, 2026
- ARS Annual report sent to shareholders May 1, 2025
- UPLOAD Comment letter from SEC staff Aug 6, 2024
- EFFECT Notice that a registration became effective Aug 5, 2024
Everything here comes from Avalo Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.